Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash flows (used in) provided by operating activities:
Net loss	$ (32,462)	$ (34,291)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Depreciation and amortization	10,031	10,959
Write-off of deferred loan costs	2,748	0
Amortization of deferred loan costs and debt discounts	8,397	2,040
Allowance for credit losses	67	352
Foreign currency (gains) losses	(185)	1,122
Deferred income taxes	(799)	(920)
Gain on asset disposals	(2,306)	(18)
Non-cash compensation (credits) costs	(624)	2,330
Other, net	(1,216)	(1,219)
Changes in operating assets and liabilities:
Accounts receivable	(18,546)	(1,601)
Inventory	(1,284)	356
Prepaid expenses and other current assets	(5,902)	2,009
Accounts payable	(4,722)	2,192
Other accrued liabilities	(2,884)	327
Income taxes	(319)	(821)
Net cash used in operating activities	(50,006)	(17,183)
Cash flows (used in) provided by investing activities:
Capital expenditures	(7,068)	(3,413)
Proceeds from disposal of assets	3,026	29
Net cash used in investing activities	(4,042)	(3,384)
Cash flows (used in) provided by financing activities:
Borrowings under ABL Credit Agreement, gross	104,924	0
Payments under ABL Credit Agreement, gross	(235)	0
Borrowings under ABL Facility, net	0	28,000
Borrowings under ABL Facility, gross	10,300	47,000
Payments under ABL Facility, gross	(72,300)	(56,000)
Payments for debt issuance costs	(10,345)	(2,027)
Taxes paid related to net share settlement of share-based awards	0	(101)
Issuance of common stock	9,767	0
Other	(145)	(64)
Net cash provided by financing activities	41,966	16,808
Effect of exchange rate changes on cash and cash equivalents	465	1,517
Net decrease in cash and cash equivalents	(11,617)	(2,242)
Cash and cash equivalents at beginning of period	65,315	24,586
Cash and cash equivalents at end of period	$ 53,698	$ 22,344